Search results
Results from the WOW.Com Content Network
Mapatumumab (HGS-ETR1) is an experimental human monoclonal antibody undergoing clinical trials for the treatment of cancer. [1] It targets TRAIL-R1 , also known as DR4, which is expressed on the surface of many tumor cell types.
Prognosis depends on how early the cancer is discovered and treated. For the least aggressive grade, about 90% of patients survive more than five years after diagnosis. People usually have a good survival rate at the low-grade volume of cancer. [3] For the most aggressive grade, only 10% of patients will survive one year. Tumors may recur in ...
Osteochondroma is the most common benign tumor of bone. [1] [2] The tumors take the form of cartilage-capped bony projections or outgrowth on the surface of bones . [3] [4] It is characterized as a type of overgrowth that can occur in any bone where cartilage forms bone. Tumors most commonly affect long bones around the knee and in the forearm.
In the US, osteoblastomas account for only 0.5–2% of all primary bone tumors and only 14% of benign bone tumors making it a relatively rare form of bone tumor. [ citation needed ] In regards to morbidity and mortality , conventional osteoblastoma is a benign lesion with little associated morbidity.
It may be used in some cases of hip dysplasia, an extremely painful congenital condition found in many dog breeds and some cats. [4] It is also performed in cases of trauma where the head of the femur is badly broken or severed, or in response to other diseases of the hip bone, such as Legg-Calve-Perthes' disease. It is sometimes the procedure ...
It is a benign, small tumor located in the skin of the distal areas of the legs and, less commonly, the arm; it has occurred mostly in females. EWSR1-SMAD3-positive fibroblastic tumor was named based on the finding that its tumor cells express a EWSR1-SMAD3 fusion gene. Since its initial description in 2018, a total of 15 cases have been ...
As of October 2023, specific codes for desmoid tumors will be included in the ICD-10-CM, the United States' diagnosis code system, after a request from the Desmoid Tumor Research Foundation. [51] A subcategory of D48.1, Neoplasm of uncertain behavior of connective and other soft tissue, has been created with more specific codes: [ 50 ]
Hemipelvectomy is generally reserved for the treatment of pelvic neoplasms. [1] [2] Examples of malignancies that are treated with hemipelvectomy include osteosarcoma, chondrosarcoma, and Ewing's sarcoma. [1] Rarely, hemipelvectomy is performed in settings of traumatic injury and osteomyelitis. [1]